About: Stephen L. Hoffman

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Stephen L. Hoffman Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher ORCID ID = 0000-0002-0700-9505

Attributes	Values
rdf:type	Item
owl:sameAs	Stephen L. Hoffman
description	forskare (sv) ikertzailea (eu) 연구원 (ko) araştırmacı (tr) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) epidemiòleg estatunidenc (ca) researcher ORCID ID = 0000-0002-0700-9505 (en)
rdfs:label	Stephen Hoffman (ca) Stephen L Hoffman (nl) Stephen L Hoffman (ast) Stephen L. Hoffman (en)
skos:prefLabel	Stephen Hoffman (ca) Stephen L Hoffman (nl) Stephen L Hoffman (ast) Stephen L. Hoffman (en)
name	Stephen Hoffman (ca) Stephen L Hoffman (nl) Stephen L Hoffman (ast) Stephen L. Hoffman (en)
given name	wds:Q60231547-64751D5A-D390-4942-98B0-70AEA1656B18
given name	Stephen
instance of	wds:Q60231547-2E27C79C-F472-4718-AA65-2F02025D97FE
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q60231547-A2FB45C4-7426-4FEE-A07D-180203FB39C3
Google Knowledge Graph ID	http://g.co/kg/g/11h4q8qpv7
Google Knowledge Graph ID	/g/11h4q8qpv7
skos:altLabel	Stephen Hoffman (en) Stephen L Hoffman (en) Stephen L. Hoffman (ca)
Nationale Thesaurus voor Auteursnamen ID	wds:Q60231547-6015c8bb-b9e9-4c2c-8f40-ec70c19bb0d4
occupation	wds:Q60231547-6D844368-3C3B-44F4-853F-8904FCA11DB9
employer	wds:Q60231547-7B0E0253-91B1-45B4-878F-24075A4734CB
KBR person ID	wds:Q60231547-933866C9-EFC9-4A81-81B6-7CF67D2995DC
sex or gender	wds:Q60231547-411c6837-43d6-9d4c-9f33-3e49392446a6
ISNI	wds:Q60231547-3DB2D20E-B6AF-4881-AAFB-0426D635D461
VIAF ID	wds:Q60231547-F000F7ED-26FC-444B-ACBB-28DA6EAD089B
Library of Congress authority ID	wds:Q60231547-CB8B8A03-9E41-4FDE-BD24-2794E1343380
IdRef ID	wds:Q60231547-6CE37779-2403-48D7-841F-BB59F0CC4591
family name	wds:Q60231547-24C3BA38-0017-4393-82A6-D81DA97A803B
WorldCat Identities ID (superseded)	wds:Q60231547-E710F3F3-A249-4284-B9C5-95D9FD1D6485
Nationale Thesaurus voor Auteursnamen ID	http://data.bibliotheken.nl/id/thes/p080639798
VIAF ID	http://viaf.org/viaf/9121063
Library of Congress authority ID	http://id.loc.gov/authorities/names/n96800214
IdRef ID	http://www.idref.fr/139700935/id
Nationale Thesaurus voor Auteursnamen ID	080639798
occupation	researcher
employer	Sanaria
KBR person ID	14430382
sex or gender	male
ISNI	0000000067629795
VIAF ID	9121063
Library of Congress authority ID	n96800214
IdRef ID	139700935
family name	Hoffman
WorldCat Identities ID (superseded)	lccn-n96800214
ORCID iD	wds:Q60231547-CEC47E87-A524-47C1-80B0-6A332C77CF36
ORCID iD	https://orcid.org/0000-0002-0700-9505
ORCID iD	0000-0002-0700-9505
is about of	Stephen L. Hoffman https://www.wikidata.org/wiki/Special:EntityData/Q60231547 Stephen L. Hoffman
is author of	Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity Toward clinical trials of DNA vaccines against malaria Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys. The Malaria Genome Sequencing Project A multilateral effort to develop DNA vaccines against falciparum malaria Prevention and treatment of vivax malaria Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Plague in the United States: the "black death" is still alive A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites Malaria vaccine development Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia Rehydration and maintenance therapy of cholera patients in Jakarta: citrate-based versus bicarbonate-based oral rehydration salt solution Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites A genetically attenuated malaria vaccine candidate based on P. falciparum b9/slarp gene-deficient sporozoites Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications. Incidence of symptomatic and asymptomatic plasmodium falciparum infection following curative therapy in adult residents of northern Ghana Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine Halofantrine and primaquine for radical cure of malaria in Irian Jaya, Indonesia Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine Utilization of genomic sequence information to develop malaria vaccines Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software